Soodeh Rajabi
Overview
Explore the profile of Soodeh Rajabi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
52
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zangiabadi I, Askaripour M, Rajizadeh M, Badreh F, Bagheri M, Jafari E, et al.
BMC Pharmacol Toxicol
. 2025 Jan;
26(1):13.
PMID: 39844289
Movento an insecticide containing spirotetramat, has been shown to cause severe toxicity in humans and rats. Due to the widespread use of the Movento in agriculture, and since the cardiac...
2.
Mokhtarian R, Rajabi S, Zahedian S, Jafarinejad-Farsangi S, Hadizadeh M, Sadeghinejad M
Ann Pharm Fr
. 2024 Feb;
82(4):629-640.
PMID: 38367937
Breast cancer (BC) is the most prevalent malignancy in women and the second most common disease worldwide, affecting approximately one million individuals annually. Despite the efficacy of conventional chemotherapy, medication...
3.
Rajabi S, Saberi S, Najafipour H, Askaripour M, Rajizadeh M, Shahraki S, et al.
Mol Biol Rep
. 2024 Jan;
51(1):137.
PMID: 38236310
Kidney fibrosis is one of the complications of chronic kidney disease (CKD (and contributes to end-stage renal disease which requires dialysis and kidney transplantation. Several signaling pathways such as renin-angiotensin...
4.
Beik A, Najafipour H, Joukar S, Rajabi S, Masoumi-Ardakani Y, Dabiri S, et al.
Pulm Circ
. 2023 Mar;
13(1):e12207.
PMID: 36937151
Pulmonary arterial hypertension (PAH) is a severe disease that leads to pulmonary vascular remodeling characterized by a rise in pulmonary vascular resistance and pressure. We assessed the effects of an...
5.
Askaripour M, Najafipour H, Saberi S, Yazdani S, Jafarinejad-Farsangi S, Rajabi S, et al.
Iran J Basic Med Sci
. 2022 Dec;
25(11):1317-1325.
PMID: 36474573
Objectives: Chronic kidney disease (CKD), accompanied by renal dysfunction, fibrosis, and apoptosis, is highly prevalent in postmenopausal women. We tested the hypothesis that isoflavone daidzein may ameliorate renal dysfunction and...
6.
Askaripour M, Najafipour H, Saberi S, Jafari E, Rajabi S
Iran J Kidney Dis
. 2022 Mar;
1(1):32-43.
PMID: 35271498
Introduction: Chronic kidney disease (CKD) is a health problem in postmenopausal women, and renal fibrosis is a common feature of CKD. In the renin-angiotensin system, oxidative stress and inflammation are...
7.
Rajabi S, Najafipour H, Sheikholeslami M, Jafarinejad-Farsangi S, Beik A, Askaripour M, et al.
Noncoding RNA Res
. 2022 Feb;
7(1):27-33.
PMID: 35155877
Background: Non-coding RNAs, including long non-coding RNAs (lncRNAs) and microRNAs (miRNAs), play critical roles in the pathogenesis and progression of pulmonary artery hypertension (PAH). LncRNA H19, myocardial infarction-associated transcript (MIAT),...
8.
Rajabi S, Najafipour H, Jafarinejad-Farsangi S, Joukar S, Beik A, Askaripour M, et al.
J Cardiovasc Pharmacol
. 2021 May;
77(6):777-786.
PMID: 34016844
Pulmonary arterial hypertension (PAH) is a pulmonary vascular disease causing right ventricular (RV) hypertrophy, failure, and death. Some miRNAs are involved in the pathophysiology of PAH. As the current treatments...
9.
Beik A, Najafipour H, Joukar S, Rajabi S, Iranpour M, Kordestani Z
Clin Exp Hypertens
. 2020 Dec;
43(3):270-280.
PMID: 33322932
: Pulmonary arterial hypertension (PAH) is a disastrous disease that current treatments cannot prevent its progression. The present study investigated the effects of perillyl alcohol (PA), a natural monoterpene, on...
10.
Rajabi S, Najafipour H, Farsangi S, Joukar S, Beik A, Iranpour M, et al.
BMC Complement Med Ther
. 2020 Jul;
20(1):218.
PMID: 32660602
Background: Pulmonary artery hypertension (PAH) is a vascular disease in the lung characterized by elevated pulmonary arterial pressure (PAP). Many miRNAs play a role in the pathophysiology of PAH. Perillyle...